Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A giant touchscreen computer for junior doctors and medical students to study tumours in fine detail is the latest weapon in the battle against cancer at Oxford’s John Radcliffe Hospital.

Dr Clare Verrill taught the first session to histopathology registrars using the new giant touchscreen
Dr Clare Verrill taught the first session to histopathology registrars using the new giant touchscreen

Cancer Research UK Oxford Centre has funded the 55-inch wide screen for the teaching of histopathology speciality trainees and medical students from the University of Oxford and the 500 researchers and clinicians that make up the Oxford Centre.

It allows users to “pinch and pull images” to identify the features of tumours that could predict their prognosis.

Until now, junior doctors and medical students have had to use microscopes linked to other microscopes used by teachers.

With the new technology, users can manipulate images – which are sent to the hospital pathology department - by zooming in and out and moving and rotating the images.

It is hoped the technology will improve the teaching of junior doctors and medical students so they can provide the best possible cancer diagnosis to patients.

The £25,780 computer has been funded by the Cancer Research UK Oxford Centre and draws on more than 400 scanned images from Oxford University Hospitals NHS Foundation Trust patients.

The first session took place on February 23 for urological pathology to prepare histopathology registrars for upcoming fellowship of the Royal College of Pathologists’ exams.

Having this digital screen enables a new and exciting way of teaching where learners and teachers are able to interact with the images. - Dr Clare Verrill

Dr Clare Verrill, Senior Clinical Lecturer in Pathology at the Nuffield Department of Surgical Sciences, who taught the first session, said: 'Having this digital screen, enables a new and exciting way of teaching where learners and teachers are able to interact with the images and makes for stimulating and interesting discussions.

'With an increasing trend for use of digital pathology images for routine diagnostics as well as research, histopathology registrars will be better equipped for modern pathology practice.'

Histopathology speciality trainee Dr Andrew Smith said: “Histopathology training is driven by practical experience - you have to look at a lot of cases to learn how to recognise tumours for what they are.  

“Having access to cases digitally and in high resolution means you can learn from a case even when the slides for that case are not available in the department.

“I think using interactive technology in this way also makes the subject more accessible.  Hopefully it will inspire more medical students and junior doctors to pursue a career in histopathology.”

Dr Claire Bloomfield, Strategic Planning Lead at the Cancer Research UK Oxford Centre, said: 'Supporting our future leaders in cancer diagnostic is a key aim for the Cancer Research UK Oxford Centre.

'Effective, detailed diagnosis is a key foundation in our vision of making cancer therapies more targeted to individual patients.'

Dr Áine McCarthy, Cancer Research UK’s science information officer, said: 'This technology offers a unique way for junior doctors and medical students to study the art of histopathology, a hugely important area of medicine.

'By using state of the art technology, we’re offering these doctors and students better training which will benefit both them and patients in the future.'

Press release courtesy of Oxford University Hospital NHS Foundation Trust.

 

Watch Dr Clare Verrill on BBC Oxford News demonstrating how to analyse a tumour using the giant touchscreen computer. The clip was aired on 26 February 2016.

Similar stories

Government boost for digitisation and AI in pathology services

Awards and appointments Clinical Women

Oxford University Hospitals (OUH) is one of the NHS trusts that will benefit from a £13.5m national funding boost to further enhance cellular pathology services and provide faster and more accurate diagnosis of deadly diseases such as cancer.

QUOD enters partnership with Evotec

Clinical

Evotec SE, a drug discovery and development solutions company, today announced a partnership agreement with the University of Oxford regarding access to biospecimens from the biobank Quality in Organ Donation (QUOD), an initiative of the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford in close collaboration with the National Health Service Blood and Transplant (NHSBT) organisation in the UK.

How Oxford Medical Sciences is fighting Coronavirus

Clinical Research

Researchers from across the Medical Sciences Division are working hard to combat the COVID-19 crises. With particular strengths in infectious diseases and international health, we are well placed to contribute to better understanding and effectively controlling the epidemic.

Engaging with tomorrow's future scientists and surgeons at Swindon's Science Festival

Public engagement Research Women

On Saturday 22 February, a team from the Nuffield Department of Surgical Sciences (NDS) enjoyed a day engaging with some of tomorrow's future scientists and surgeons at Swindon's first science festival.

Professor Clare Verrill collaborates on international cancer genomes project

Publication Research Women

Professor Clare Verrill from the Nuffield Department of Surgical Sciences at the University of Oxford has contributed to the publication of The Pan-Cancer Analysis of Whole Genomes (PCAWG) project.

Study reveals how cancer cells use bone marrow fat for growth and survival

Publication Research Women

As society battles with an obesity epidemic, new research from the Edwards group shows how increased body fat contributes to cancer establishment and progression.